使用lenacapavir和 fostemsavir有效管理多药耐药性HIV:一个案例研究
Francisca Bartilotti Matos1, Dara Mbanze1, Perpétua Gomes2,3
1Serviço de Doenças Infeciosas, Unidade Local de Saúde Gaia/Espinho, Vila Nova de Gaia, Portugal.
International journal of STD & AIDS
|November 1, 2024
概括
一名患有多抗药性HIV的患者在使用lenacapavir和 fostemsavir时在一个月内实现了无法检测的病毒载量. 这种组合疗法在治疗复杂的HIV耐药性病例方面表现有前途,没有发现严重的副作用.
科学领域:
- 传染性疾病 传染性疾病
- 病毒学 病毒学
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗逆转录病毒疗法耐药性在控制人类免疫缺陷病毒 (HIV) 感染方面构成了重大挑战.
- 患有多种治疗方案的患者往往会对常规抗逆转录病毒药物产生耐药性.
- 需要新的治疗药物来解决复杂的HIV耐药性病例.
研究的目的:
- 报告患者多药耐药性艾滋病病毒的成功治疗,使用lenacapavir和 fostemsavir的组合.
- 在临床环境中评估这种新型组合疗法的疗效和安全性.
主要方法:
- 一个单个患者的案例研究,该患者有记录的多药耐药性HIV病史.
- 治疗涉及lenacapavir和 fostemsavir的组合疗法.
- 患者的病毒载量和不良事件在一年内被监测.
主要成果:
- 患者在启动莱纳卡巴维尔和福特姆萨维尔联合治疗后一个月内实现了无法检测的病毒载量.
- 持续的病毒抑制维持了一年.
- 在治疗期间没有报告严重的不良副作用.
结论:
- 联用lenacapavir和 fostemsavir的联合使用可以有效地管理多药耐药性HIV.
- 这一案例凸显了这些新药在复杂的艾滋病毒治疗场景中实现持续病毒抑制的潜力.
- 需要进一步研究lenacapavir和 fostemsavir对HIV耐药性的联合使用.
更多相关视频
相关概念视频
Retrovirus Life Cycles
45.7K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.7K
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Cystic Fibrosis: Management
143
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
143
Acute Respiratory Failure-V
123
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
123


